Form 4: Ardelyx Chief Medical Officer Reports Stock Sale to Cover Taxes
SEC Form 4 Filing
Laura A. Williams, Chief Medical Officer of Ardelyx, Inc., sold shares of common stock to cover withholding taxes upon the vesting of restricted stock units.
Summary
- On May 21, 2024, Laura A. Williams, Chief Medical Officer of Ardelyx, Inc., sold 4,794 shares of common stock.
- The sale was executed at a price of $7.811 per share.
- The transaction was an automatic sell-to-cover imposed by the terms of the restricted stock units (RSUs) awards to cover applicable withholding taxes upon vesting.
- Following the transaction, Williams beneficially owns 367,152 shares of Ardelyx common stock, which includes 1,757 shares purchased under the Ardelyx Employee Stock Purchase Plan in February 2024.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sell-to-cover for taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Key Dates
| Date | Description |
|---|---|
| February 2024 | Purchase of 1,757 shares under the Ardelyx Employee Stock Purchase Plan |
| 05/21/2024 | Sale of 4,794 shares of common stock at $7.811 per share |
| 05/23/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.